1.92

1.05% 0.02

Pre-market: 1.92

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $1.92, with a volume of 408.39K. It is up +1.05% in the last 24 hours and down -1.03% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$1.90

Open:

$1.92

24h Volume:

408.39K

Relative Volume:

0.99

Market Cap:

$187.65M

Revenue:

$32.38M

Net Income/Loss:

$-21.64M

P/E Ratio:

-7.6281

EPS:

-0.2517

Net Cash Flow:

$-13.78M

1W Performance:

+3.78%

1M Performance:

-1.03%

6M Performance:

-17.24%

1Y Performance:

-4.95%

1-Day Range:

$1.88

$1.95

1-Week Range:

$1.70

$1.95

52-Week Range:

$1.70

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1106)

Industry

Medical Instruments & Supplies (55)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2026-05-12

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	1.92	185.70M	32.38M	-21.64M	-13.78M	-0.2517
ISRG Intuitive Surgical Inc	438.10	155.76B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	147.63	40.30B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.78	33.13B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	37.01	31.37B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	208.05	30.31B	5.54B	1.52B	1.74B	10.37

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-25	Initiated	Citizens JMP	Mkt Outperform
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

May 25, 2026

Stereotaxis (STXS) Edges Higher: Navigating the Robotics Sector with Modest GainsVolatility Term Structure - Newser

May 25, 2026

May 24, 2026

Stereotaxis Emerges as Notable Oversold Play in AI Sector with Over 120 Percent Implied Upside - HarianBasis.co

May 24, 2026

Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why - Insider Monkey

May 24, 2026

May 23, 2026